An Automated MS Data Workflow Enabling Targeted, Site-Specific N-Glycosylation Monitoring of Biopharmaceuticals
Customer Company Size
Large Corporate
Region
- America
Country
- United States
Product
- Genedata Expressionist
Tech Stack
- LC-MS glycopeptide mapping method
- 2-AB UHPLC method
Implementation Scale
- Enterprise-wide Deployment
Impact Metrics
- Productivity Improvements
- Innovation Output
Technology Category
- Analytics & Modeling - Big Data Analytics
- Analytics & Modeling - Real Time Analytics
Applicable Industries
- Pharmaceuticals
Applicable Functions
- Product Research & Development
- Quality Assurance
Use Cases
- Predictive Quality Analytics
- Root Cause Analysis & Diagnosis
Services
- Data Science Services
About The Customer
The customer in this case study is a biopharmaceutical developer, likely a large-scale company given the mention of sales of antibody-based therapeutics totaling around $100 billion in the U.S. alone. The company is involved in the development of monoclonal antibodies (mAbs), which are currently the largest and fastest-growing class of biopharmaceutical. These mAbs undergo post-translational modifications (PTMs), including N-linked glycosylation, which modulates antibody activity and can affect a therapeutic antibody’s immunogenicity and pharmacokinetics. The company is seeking to understand how cellular conditions and biotechnical process parameters modulate N-glycosylation to establish robust manufacturing processes and safer therapeutics.
The Challenge
The biopharmaceutical industry is constantly seeking strategies to improve the quality and effectiveness of their products. One such strategy is the characterization and control of glycosylation patterns. However, the current gold standard for N-glycan mapping, ultrahigh pressure liquid chromatography (UHPLC) with a fluorescence-based detection method, presents several limitations. It loses site-specific information for molecules with multiple glycosylation sites, has issues with co-elution and new peak appearance, and requires laborious data processing, analysis, and reporting. The need for a more robust and high-throughput glycan analysis methodology led to the exploration of LC-MS glycopeptide mapping.
The Solution
The solution involved streamlining the data processing workflow of LC-MS glycopeptide mapping by automating the processing steps using Genedata Expressionist. This software allows for the detection of each targeted glycopeptide, automatically reports its mass-to-charge ratio and retention time, directly groups isomers (including newly discovered ones), and can visualize data at any point within the workflow. Users can also create “approved” workflows by blocking edits to selected parameters or the entire workflow, simplifying usage in routine monitoring and allowing the workflows to be used by non-experts. This method provides site-specific monitoring with no co-elution issues, identifies new peaks directly, and is suitable for complex molecules.
Operational Impact
Quantitative Benefit
Case Study missing?
Start adding your own!
Register with your work email and create a new case study profile for your business.
Related Case Studies.
Case Study
Case Study: Pfizer
Pfizer’s high-performance computing software and systems for worldwide research and development support large-scale data analysis, research projects, clinical analytics, and modeling. Pfizer’s computing services are used across the spectrum of research and development efforts, from the deep biological understanding of disease to the design of safe, efficacious therapeutic agents.
Case Study
Fusion Middleware Integration on Cloud for Pharma Major
Customer wanted a real-time, seamless, cloud based integration between the existing on premise and cloud based application using SOA technology on Oracle Fusion Middleware Platform, a Contingent Worker Solution to collect, track, manage and report information for on-boarding, maintenance and off-boarding of contingent workers using a streamlined and Integrated business process, and streamlining of integration to the back-end systems and multiple SaaS applications.
Case Study
Process Control System Support
In many automated production facilities, changes are made to SIMATIC PCS 7 projects on a daily basis, with individual processes often optimised by multiple workers due to shift changes. Documentation is key here, as this keeps workers informed about why a change was made. Furthermore, SIMATIC PCS 7 installations are generally used in locations where documentation is required for audits and certification. The ability to track changes between two software projects is not only an invaluable aid during shift changes, but also when searching for errors or optimising a PCS 7 installation. Every change made to the system is labour-intensive and time-consuming. Moreover, there is also the risk that errors may occur. If a change is saved in the project, then the old version is lost unless a backup copy was created in advance. If no backup was created, it will no longer be possible to return to the previous state if and when programming errors occur. Each backup denotes a version used by the SIMATIC PCS 7 system to operate an installation. To correctly interpret a version, information is required on WHO changed WHAT, WHERE, WHEN and WHY: - Who created the version/who is responsible for the version? - Who released the version? - What was changed in the version i.e. in which block or module of the SIMATIC PCS 7 installation were the changes made? - When was the version created? Is this the latest version or is there a more recent version? - Why were the changes made to the version? If they are part of a regular maintenance cycle, then is the aim to fix an error or to improve production processes? - Is this particular version also the version currently being used in production? The fact that SIMATIC PCS 7 projects use extremely large quantities of data complicates the situation even further, and it can take a long time to load and save information as a result. Without a sustainable strategy for operating a SIMATIC PCS 7 installation, searching for the right software version can become extremely time-consuming and the installation may run inefficiently as a result.
Case Study
Drug Maker Takes the Right Prescription
China Pharm decided to build a cloud-based platform to support the requirements of IT planning for the next five to ten years which includes a dynamic and scalable mail resource pool platform. The platform needed to have the following functions: all nodes support redundancy, ensuring service continuity and good user experience, simple and easy-to-use user interfaces for end users and administrators and good compatibility and supports smooth capacity expansion.
Case Study
ELI LILLY ADOPTS MICROMEDIA’S ALERT NOTIFICATION SYSTEM
Pharmaceutical production is subject to a strict set of enforced rules that must be adhered to and compliance to these standards is critically necessary. Due to the efforts of WIN 911’s strategic partner Micromedia, Lilly was able to adopt an alarm notification infrastructure that integrated smoothly with their existing workflows and emergency hardware and protocols. These raw energy sources enable the industrial process to function: electricity, WIN-911 Software | 4020 South Industrial Drive, Suite 120 | Austin, TX 78744 USA industrial steam, iced water, air mixtures of varying quality. Refrigeration towers, boilers and wastewater are monitored by ALERT. Eli Lilly identified 15000 potential variables, but limitations compelled them to chisel the variable list down to 300. This allowed all major alarms to be covered including pressure, discharge, quantity of waste water discharged,temperature, carbon dioxide content, oxygen & sulphur content, and the water’s pH.
